ATE224889T1 - Substituierte bisindolylmaleimide zur inhibierung der zellproliferation - Google Patents

Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Info

Publication number
ATE224889T1
ATE224889T1 AT97918934T AT97918934T ATE224889T1 AT E224889 T1 ATE224889 T1 AT E224889T1 AT 97918934 T AT97918934 T AT 97918934T AT 97918934 T AT97918934 T AT 97918934T AT E224889 T1 ATE224889 T1 AT E224889T1
Authority
AT
Austria
Prior art keywords
bisindolylmaleimide
substituted
cell proliferation
inhibit cell
inhibit
Prior art date
Application number
AT97918934T
Other languages
English (en)
Inventor
Urvashi Hooda Dhingra
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE224889T1 publication Critical patent/ATE224889T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97918934T 1996-07-29 1997-07-19 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation ATE224889T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US4849697P 1997-06-03 1997-06-03
PCT/EP1997/003888 WO1998004551A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (1)

Publication Number Publication Date
ATE224889T1 true ATE224889T1 (de) 2002-10-15

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918934T ATE224889T1 (de) 1996-07-29 1997-07-19 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Country Status (20)

Country Link
US (1) US6228877B1 (de)
EP (1) EP0915870B1 (de)
JP (1) JP2000516588A (de)
KR (1) KR20000029640A (de)
CN (1) CN1077571C (de)
AR (1) AR007969A1 (de)
AT (1) ATE224889T1 (de)
AU (1) AU740011B2 (de)
BR (1) BR9711607A (de)
CA (1) CA2262089A1 (de)
CO (1) CO4900054A1 (de)
DE (1) DE69715870T2 (de)
DK (1) DK0915870T3 (de)
ES (1) ES2183163T3 (de)
HR (1) HRP970415A2 (de)
MA (1) MA24354A1 (de)
PE (1) PE91598A1 (de)
PT (1) PT915870E (de)
TR (1) TR199900186T2 (de)
WO (1) WO1998004551A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228831B1 (en) * 1998-03-17 2013-05-28 Hoffmann La Roche Substituted bisindolylmaleimides, their use and pharmaceutical compositions containing them
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
RU2002110111A (ru) * 1999-10-12 2003-12-20 Ф.Хоффманн-Ля Рош Аг (Ch) Замещенные пирролы в качестве антипролиферативных средств для лечения рака
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
AU2002342193B2 (en) * 2001-10-29 2006-10-26 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase C inhibitors
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP2289892B1 (de) 2005-02-09 2012-08-22 ArQule, Inc. Maleimid-derivate, pharmazeutischen Zusammensetzungen, und Verfahren zur Krebsbehandlung
WO2008074752A2 (en) 2006-12-19 2008-06-26 Novartis Ag Indolylmaleimide derivatives as kinase inhibitors
WO2009002806A1 (en) * 2007-06-22 2008-12-31 Arqule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
CA2912546A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Compositions and methods for treatment of cancer
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムＩｎｓｅｒｍ 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN105777751B (zh) * 2016-04-26 2018-12-11 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
WO1993018765A1 (en) 1992-03-20 1993-09-30 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
DE69715870D1 (de) 2002-10-31
DK0915870T3 (da) 2003-02-03
MA24354A1 (fr) 1998-07-01
US6228877B1 (en) 2001-05-08
AU740011B2 (en) 2001-10-25
TR199900186T2 (xx) 1999-03-22
AR007969A1 (es) 1999-11-24
BR9711607A (pt) 1999-08-24
EP0915870B1 (de) 2002-09-25
JP2000516588A (ja) 2000-12-12
CN1226248A (zh) 1999-08-18
CN1077571C (zh) 2002-01-09
WO1998004551A1 (en) 1998-02-05
AU4296397A (en) 1998-02-20
PT915870E (pt) 2003-01-31
CA2262089A1 (en) 1998-02-05
KR20000029640A (ko) 2000-05-25
HRP970415A2 (en) 1998-08-31
ES2183163T3 (es) 2003-03-16
EP0915870A1 (de) 1999-05-19
CO4900054A1 (es) 2000-03-27
PE91598A1 (es) 1998-12-24
DE69715870T2 (de) 2003-06-18

Similar Documents

Publication Publication Date Title
ATE224889T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
ATE240318T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE69735060D1 (de) Einheit zur befeuchtungseinstellung
DE69739407D1 (de) Plattenstruktur
ID19875A (id) Poliolefin yang dimodifikasi menurut reologi
DE69727942D1 (de) Transplantat-gewebekonstruktion zum ersatz der knorpelstruktur
NO984316D0 (no) Skjµreverkt°y
ID24314A (id) Tempat umpan bersekat-sekat
DE69718481D1 (de) Elektrolyt
ATE243693T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
NO990552L (no) Innrettingsverkt°y
ATE347551T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
ATE306484T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE29615909U1 (de) Bautafel
ID17786A (id) Sel fotoelektrokima
DE19780470T1 (de) Multivibratorschaltung
DE29615098U1 (de) Taubenzelle
ATA196697A (de) Panzerungsplatte
ID16641A (id) Peralatan elektromagnit untuk mengukur tenaga listrik
FR2743284B1 (fr) Assiette papillote
DE29601146U1 (de) Dämmplatte
DE19780481T1 (de) Multivibratorschaltung
ID18647A (id) Gurdi bor bebatuan
ID18947A (id) Pesawat untuk menjepit piringan
BR7601913U (pt) Disposição construtiva aplicada em plantadeira-adubadeira

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0915870

Country of ref document: EP

REN Ceased due to non-payment of the annual fee